Brief: Viatris Q2 Adjusted EPS USD 0.69 Vs. IBES Estimate USD 0.6
06/08/2026 12:00
BRIEF-Viatris Q2 Adjusted EPS USD 0.69 Vs. IBES Estimate USD 0.6 Aug 06 (Reuters) - Viatris Q2 EPS USD -0.1.
- Q2 revenue USD 3,756.8 million vs. IBES estimate USD 3,675 million
- Q2 net income USD -118.8 million
- outlook FY revenue USD 14,550-14,950 million vs. IBES estimate USD 14,783 million
- outlook FY adjusted EPS USD 2.45-2.59 vs. IBES estimate USD 2.44
Recent news on Viatris
See all newsBrief: Viatris Receives U.S. FDA Approval For Ryzumvi® For The Treatment Of Presbyopia
Pacira BioSciences jumps on $1.65 billion Viatris buyout deal
Deals of the day-Mergers and acquisitions
Brief: Viatris - Pacira To Pay Viatris $62 Million Termination Fee Under Specified Circumstances
Pacira BioSciences jumps on $1.65 billion Viatris buyout deal